News

Published on 6 Oct 2022 on Zacks via Yahoo Finance

SmileDirectClub (SDC) Hurt by Lower Spending, Margin Woe


Article preview image

SmileDirectClub’s SDC ongoing operating loss, leveraged balance sheet and tough competitive landscape remain overhangs. The stock currently carries a Zacks Rank #4 (Sell).

Over the past year, shares of SmileDirectClub have underperformed the broader industry. The stock has declined 84.4% compared with the industry’s 13.6% fall. SmileDirectClub exited the second quarter of 2022 with lower-than-expected earnings. The company registered a year-over-year decline in revenues in the quarter due to lower unique aligner shipments. The company also witnessed a drop in both net and financing revenues on a year-over-year basis.

Throughout the second quarter, the macroeconomic challenges continued to impact SmileDirectClub’s core demographic and business spending. According to the company, challenges to consumer spending accelerated faster than anticipated during the quarter. These, combined with reduced stimulus, sustained high inflation and a shift in discretionary spending toward services, will result in less predictable demand curves and lower overall expected demand in the balance of the year. Accordingly, SmileDirectClub reduced its 2022 guidance.

NYSE.MCK price evolution
NYSE.AMN price evolution

Want to become a better investor?

Start tracking your investments with Statfolio

Sign up for free
Related News
Revenue Cycle Management Market to Witness Remarkable Growth as Healthcare Providers Seek to...

Revenue Cycle Management Market Report Scope and Overview The global Revenue Cycle Management Mar...

Digital Journal 23 Apr 2024

Small Business - The Brewton Standard | The Brewton Standard

The Electronic Health Records (HER) market held a value of USD 29.15 billion in 2023 with a...

The Brewton Standard 23 Apr 2024

Healthcare IT Market Size Worth USD 1827.12 billion By 2031

The global Healthcare IT Market is booming, fueled by the digitization of medical records,...

Digital Journal 23 Apr 2024

Cardinal Health maintains stock target despite contract loss By Investing.com

On Monday, TD Cowen maintained a Hold rating on Cardinal Health (NYSE:CAH) with a steady stock pr...

Investing.com 22 Apr 2024

Why McKesson (MCK) is a Top Value Stock for the Long-Term

For new and old investors, taking full advantage of the stock market and investing with confidenc...

Zacks via Yahoo Finance 19 Apr 2024

Jim Cramer Is 'Willing To Let This Pharma Stock Catch Fire,' Advises Not To Sell McKesson -...

On CNBC's “Mad Money Lightning Round,” Jim Cramer recommended holding ConocoPhillips COP Rhythm P...

Benzinga 19 Apr 2024

14 Best 52-Week High Stocks To Invest In Now

This article delves into the examination of the 14 best 52-week high stocks to buy now. To explor...

Insider Monkey via Yahoo Finance 16 Apr 2024

McKesson's (NYSE:MCK) investors will be pleased with their fantastic 384% return over the last five...

Long term investing can be life changing when you buy and hold the truly great businesses. And we...

Simply Wall St. via Yahoo Finance 7 Apr 2024

13 Best Cheap Dividend Stocks To Buy Right Now

In this article, we discuss 13 best cheap dividend stocks to buy right now. You can skip our deta...

Insider Monkey via Yahoo Finance 6 Apr 2024

McKesson stock target raised on strong earnings outlook

On Friday, Baird increased its price target for McKesson Corporation (NYSE: MCK ) to $603 from th...

Investing.com 5 Apr 2024